Phase 2 Colorectal Cancer Trial, Recruiting NCT03957902 Sponsor: Instituto de Investigación Sanitaria Aragón Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 2 Colorectal Cancer Trial, Recruiting

NCT03957902
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are aged 18 or older but under 80 years old
  • You have recently been diagnosed with colon or rectal cancer within the last 48 hours, confirmed by a camera examination of the bowel and a laboratory analysis of tissue samples
  • Your blood clotting and general blood test results are within a normal range, with no significant abnormalities that could affect the study (confirm with trial site)

Who may not be able to join:

  • You are allergic to aspirin or any similar anti-inflammatory painkiller (such as ibuprofen or naproxen)
  • You have rectal cancer that requires pre-surgery treatment (such as chemotherapy or radiotherapy) starting within two weeks of beginning the study medication
  • You have taken aspirin, anti-inflammatory painkillers, blood-thinning medications, steroids, or a drug called misoprostol in the 15 days before your diagnosis, or you are expected to need any of these drugs during the study
  • You have a history of stomach ulcers, a current stomach ulcer, or any other gut condition that would make taking aspirin unsafe, unless you are also taking stomach-protecting medication
  • You have been diagnosed with a bleeding disorder
  • You have had another type of cancer (other than certain common skin cancers) in the past 3 years
  • You have serious other health conditions, such as significant breathing, heart, liver, or kidney disease (diabetes is not a reason to be excluded)
  • You are currently an active smoker
  • You are pregnant or breastfeeding
  • You have a history of drug or alcohol misuse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Ángel Lanas Arbeloa, MD, Instituto de Investigación Sanitaria Aragón

Phone: 0034976765786

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Instituto de Investigación Sanitaria Aragón
Registry
ClinicalTrials.gov
Start date
6 May 2019
Est. completion
1 May 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Assessment of changes in acetylation levels of COX enzymes in platelets and non-neoplastic and neoplastic colonic tissues

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov